Does cannabis extract obtained from cannabis flowers with maximum allowed residual level of aflatoxins and ochratoxin A have an impact on human safety and health?
Posted on March 8, 2022 By LabLynx Journal articles
Contents
Add links
Tools
Actions
General
- What links here
- Related changes
- Upload file
- Special pages
- Permanent link
- Page information
- Cite this page
- Get shortened URL
- Download QR code
- Wikidata item
Print/export
- Download as PDF
- Printable version
Appearance
Chemical compound
![]() | |
Identifiers | |
---|---|
| |
CAS Number |
|
Chemical and physical data | |
Formula | C23H30N2OS |
Molar mass | 382.57 g·mol−1 |
3D model (JSmol) | |
| |
|
A-PBITMO is a synthetic cannabinoid receptor agonist that has been sold as a designer drug, first reported in Germany in July 2023,[1] and also subsequently identified in Russia.[2] It has an unusual 1,3-dihydrobenzimidazole-2-thione core structure which has not previously been seen in cannabinoid designer drugs.
See also
References
- ^ "New psychoactive substances - the current situation in Europe" (PDF). European Drug Report. European Union Drugs Agency (EUDA). 2024.
- ^ Yurchenko RA, Yurchenko LV, Galetskaya IA, Novitsky MV, Pavlovets YS (February 2024). Psychoactive products market observation. Trend analysis (Report) (in Russian). Aipsin. doi:10.13140/RG.2.2.10176.92163.
Receptor (ligands) |
| ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (modulators) |
| ||||||||||||||||||||||||||||||
Enzyme (modulators) |
| ||||||||||||||||||||||||||||||
Others |
| ||||||||||||||||||||||||||||||
|
![](https://limsforum.com/images/mystery-man-50.jpg)
by LabLynx
Related Posts